Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.05
+0.02 (0.28%)
At close: Apr 28, 2026, 4:00 PM EDT
7.00
-0.05 (-0.71%)
After-hours: Apr 28, 2026, 6:51 PM EDT
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$189,412
Profits / Employee
$5,395,647
Market Cap
28.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| BriaCell Therapeutics | 16 |
| Lantern Pharma | 16 |
| Apollomics | 13 |
| Tvardi Therapeutics | 12 |
| Neuphoria Therapeutics | 8 |
KYNB News
- 15 days ago - Kyntra Bio Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Kyntra Bio Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Kyntra Bio Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Kyntra Bio Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - What's Going On With Kyntra Bio Stock Tuesday? - Benzinga